Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by DJDawgon Feb 12, 2023 2:44pm

777 Views

Post# 35282170

fyi for tomorrow

ASCU GU dates pages

FEBRUARY 13, 2023 at 5:00 PM (ET) - Regular Abstracts Released on ASCO's Digital Program

Not exactly sure that this means what I think it means but there could be an abstract released tomorrow afternoon/evening.

Having said that the deadlines for the applications suggest that the data submitted would have been from way back in October so could be limited new info.

The poster itself on the other hand, next weekend, may be the first display of each patient's journey. Rather than the confusing tables that TLT issues.

Interesting days to come.